|
|
|
|
|
|
|
|
|
11.07.25 - 16:00
|
Walgreens Boots Alliance Shareholders Overwhelmingly Approve Transaction with Sycamore Partners (Business Wire)
|
|
|
Transaction expected to close in the third or fourth quarter of calendar year 2025DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens Boots Alliance, Inc. (Nasdaq: WBA) (the “Company” or “WBA”) today announced that at the Company's Special Meeting of Shareholders (the “Special Meeting”), WBA shareholders approved the previously announced acquisition of the Company by entities affiliated with Sycamore Partners Management, L.P. (“Sycamore”).
According to the preliminary results, approximately 96% of votes cast at the Special Meeting by all shareholders were voted in favor of the merger agreement proposal. In addition, approximately 95% of the votes cast at the Special Meeting by unaffiliated shareholders were voted in favor of the merger agreement proposal.
“We appreciate the consideration and overwhelming support from our shareholders in our value-maximizing transaction with Sycamore,” said Tim Wentworth, Chief Executive Officer of Walgreens Boots Alliance. “With Sycamore's partnership, we ...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
26.06.25 - 13:18
|
Walgreens Beats Earnings Estimates as It Prepares to Go Private (Bloomberg)
|
|
|
Walgreens Boots Alliance Inc. reported quarterly profit that beat Wall Street's expectations, a hopeful sign as the pharmacy giant prepares to transform into a private company after its market value plummeted due to retail competition and lower prescription drug payments from insurance companies....
|
|
|
|
|
26.06.25 - 13:03
|
Walgreens Boots Alliance Reports Fiscal 2025 Third Quarter Results (Business Wire)
|
|
|
Third quarter financial results
Third quarter loss per share1 was $0.20 compared to earnings per share of $0.40 in the year-ago quarter. The decline in earnings per share was primarily driven by prior year after-tax gains related to fair value adjustments on variable prepaid forward derivatives and a partial sale of the Company's equity method investment in Cencora, and higher tax expense in the current quarter.
Adjusted earnings per share (EPS)2 was $0.38 compared to adjusted EPS2 of $0.63 in the year-ago quarter. The decline in adjusted EPS2 was primarily driven by a higher adjusted effective tax rate2, higher incentive accruals, lower U.S. retail sales and lower equity earnings in Cencora, partly offset by cost savings within U.S. Retail Pharmacy.
Third quarter sales increased 7.2 percent year-over-year to $39.0 billion, up 6.9 percent on a constant currency basis.
Fiscal 2025 guidance
Given the pending transaction, pursuant to which WBA will be acquired by entities affiliated with Sycamore Partners, ...
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
